A 61-year-old with recurrent CDI after initial fidaxomicin asks about prevention. Which adjunct reduces recurrence risk in high-risk adults?...

Question

A 61-year-old with recurrent CDI after initial fidaxomicin asks about prevention. Which adjunct reduces recurrence risk in high-risk adults?

Accepted Answer

Bezlotoxumab as a single infusion during antibiotic therapy

Answer

Prophylactic metronidazole

Answer

Probiotics for 6 months

Answer

Chronic vancomycin suppression

Answer

Fecal microbiota transplant as first recurrence therapy in nonsevere disease

us-abim MCQ (SBA): C. difficile Recurrence Prevention